Effects of Spirulina (Arthrospira) platensis supplementation on intestinal permeability, antioxidant and inflammatory markers, quality of life and disease severity in patients with constipated-predominant irritable bowel syndrome: a randomized double‑blind, placebo‑controlled trial

被引:0
|
作者
Saeede Jafari Nasab [1 ]
Awat Feizi [2 ]
Parisa Hajihashemi [3 ]
Mohammad-Hassan Entezari [1 ]
Manoj Sharma [4 ]
Peyman Adibi [3 ]
Mohammad Bagherniya [5 ]
机构
[1] Isfahan University of Medical Sciences,Department of Clinical Nutrition, School of Nutrition and Food Science
[2] Isfahan University of Medical Sciences,Department of Epidemiology and Biostatistics, School of Health
[3] Isfahan University of Medical Sciences,Isfahan Gastroenterology and Hepatology Research Center
[4] University of Nevada,Department of Social & Behavioral Health, School of Public Health
[5] Isfahan University of Medical Sciences,Department of Community Nutrition, School of Nutrition and Food Science
关键词
Cyanobacteria; Irritable bowel syndrome; Antioxidant capacity; Intestinal permeability;
D O I
10.1186/s12937-025-01132-6
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial
    Giannetti, Eleonora
    Maglione, Marco
    Alessandrella, Annalisa
    Strisciuglio, Caterina
    De Giovanni, Donatella
    Campanozzi, Angelo
    Miele, Erasmo
    Staiano, Annamaria
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2017, 51 (01) : E5 - E10
  • [22] Effects of Microencapsulated Sodium Butyrate, Probiotics and Short Chain Fructooligosaccharides in Patients with Irritable Bowel Syndrome: A Study Protocol of a Randomized Double-Blind Placebo-Controlled Trial
    Gasiorowska, Anita
    Romanowski, Marek
    Walecka-Kapica, Ewa
    Kaczka, Aleksandra
    Chojnacki, Cezary
    Padysz, Milena
    Siedlecka, Marta
    Bierla, Joanna B.
    Steinert, Robert E.
    Cukrowska, Bozena
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (21)
  • [24] Tong-xie-ning, a Chinese herbal formula, in treatment of diarrhea-predominant irritable bowel syndrome: a prospective, randomized, double-blind, placebo-controlled trial
    Wang Gang
    Li Ting-qian
    Wang Lei
    Xia Qing
    Chang Jing
    Zhang Ying
    Wan Mei-hua
    Guo Jia
    Cheng Yan
    Huang Xi
    Zhang Rui-ming
    CHINESE MEDICAL JOURNAL, 2006, 119 (24) : 2114 - 2119
  • [25] Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
    Spiller, Robin
    Pelerin, Fanny
    Decherf, Amelie Cayzeele
    Maudet, Corinne
    Housez, Beatrice
    Cazaubiel, Murielle
    Justen, Peter
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2016, 4 (03) : 353 - 362
  • [26] A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome
    Urgesi, R.
    Casale, C.
    Pistelli, R.
    Rapaccini, G. L.
    De Vitis, I.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (09) : 1344 - 1353
  • [27] Effects of vitamin D supplementation on intestinal permeability, cathelicidin and disease markers in Crohn's disease: Results from a randomised double-blind placebo-controlled study
    Raftery, Tara
    Martineau, Adrian R.
    Greiller, Claire L.
    Ghosh, Subrata
    McNamara, Deirdre
    Bennett, Kathleen
    Meddings, Jon
    O'Sullivan, Maria
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2015, 3 (03) : 294 - 302
  • [28] A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme α-galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients
    Bohn, Lena
    Tornblom, Hans
    Van Oudenhove, Lukas
    Simren, Magnus
    Storsrud, Stine
    NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 33 (07):
  • [29] A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome
    Kruis, Wolfgang
    Chrubasik, Sigrun
    Boehm, Stephan
    Stange, Christiane
    Schulze, Juergen
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (04) : 467 - 474
  • [30] A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome
    Wolfgang Kruis
    Sigrun Chrubasik
    Stephan Boehm
    Christiane Stange
    Juergen Schulze
    International Journal of Colorectal Disease, 2012, 27 : 467 - 474